SEARCH

SEARCH BY CITATION

References

  • 1
    Reifenberger G,Kros JM,Burger PC,Louis DN,Collins VP. Oligodendroglial tumors. In: KleihuesP,CaveneeWK, eds. Pathology and genetics—tumours of the nervous system. Lyon: IARC Press, 2000; 5669.
  • 2
    Perry JR,Louis DN,Cairncross JG. Current treatment of oligodendrogliomas. Arch Neurol 1999; 56: 4346.
  • 3
    Bello MJ,Leone PE,Vaquero J,de Campos JM,Kusak ME,Sarasa JL,Pestana A,Rey JA. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 1995; 64: 20710.
  • 4
    Cairncross JG,Ueki K,Zlatescu MC,Lisle DK,Finkelstein DM,Hammond RR,Silver JS,Stark PC,Macdonald DR,Ino Y,Ramsay DA,Louis DN. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90: 14739.
  • 5
    Smith JS,Alderete B,Minn Y,Borell TJ,Perry A,Mohapatra G,Hosek SM,Kimmel D,O'Fallon J,Yates A,Feuerstein BG,Burger PC, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999; 18: 414452.
  • 6
    Von Deimling A,Fimmers R,Schmidt MC,Bender B,Fassbender F,Nagel J,Jahnke R,Kaskel P,Duerr E,Koopmann J,Maintz D,Steinbeck S, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000; 59: 54458.
  • 7
    Hartmann C,Johnk L,Kitange G,Wu Y,Ashworth LK,Jenkins RB,Louis DN. Transcript map of the 3.7-Mb D19S112–D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res 2002; 62: 41008.
  • 8
    Maegawa S,Yoshioka H,Itaba N,Kubota N,Nishihara S,Shirayoshi Y,Nanba E,Oshimura M. Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol Carcinog 2001; 31: 19.
  • 9
    Wolf RM,Draghi N,Liang X,Dai C,Uhrbom L,Eklof C,Westermark B,Holland EC,Resh MD. p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev 2003; 17: 47687.
  • 10
    Alaminos M,Davalos V,Ropero S,Setien F,Paz MF,Herranz M,Fraga MF,Mora J,Cheung NK,Gerald WL,Esteller M. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res 2005; 65: 256571.
  • 11
    Chang Q,Pang JC,Li KK,Poon WS,Zhou L,Ng HK. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. Hum Pathol 2005; 36: 126572.
  • 12
    Dong Z,Pang JC,Ng MH,Poon WS,Zhou L,Ng HK. Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours. Br J Cancer 2004; 91: 110511.
  • 13
    Jetten Am,Suter U. The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol 2000; 64: 97129.
  • 14
    Fabbretti E,Edomi P,Brancolini C,Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Gene Dev 1995; 9: 184656.
  • 15
    Ben-Porath I,Benvenisty N. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene 1996; 183: 6975.
  • 16
    van den Bent MJ,Looijenga LHJ,Langenberg K,Dinjens W,Graveland W,Uytdewilligen L,Smitt PAS,Jenkins RB,Kros JM. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 2003; 97: 127684.
  • 17
    Tews B,Felsberg J,Hartmann C,Kunitz A,Hahn M,Toedt G,Neben K,Hummerich L,von Deimling A,Reifenberger G,Lichter P. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer 2006; 119: 792800.